Option Care Health (NASDAQ:OPCH) Sees Large Volume Increase - Here's What Happened

Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) shares saw unusually-strong trading volume on Friday . Approximately 3,834,392 shares traded hands during mid-day trading, an increase of 164% from the previous session's volume of 1,450,343 shares.The stock last traded at $24.03 and had previously closed at $23.04.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. JMP Securities raised their price target on Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a report on Monday, September 30th. Bank of America lowered shares of Option Care Health from a "buy" rating to a "neutral" rating and decreased their price target for the company from $43.00 to $29.00 in a research note on Wednesday. Jefferies Financial Group downgraded shares of Option Care Health from a "buy" rating to a "hold" rating and cut their price objective for the stock from $38.00 to $26.00 in a research report on Thursday. Truist Financial decreased their target price on Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research report on Friday. Finally, Barrington Research dropped their price target on Option Care Health from $40.00 to $32.00 and set an "outperform" rating for the company in a report on Thursday. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Option Care Health currently has an average rating of "Moderate Buy" and an average target price of $31.60.

Option Care Health Stock Up 4.6 %

The stock's fifty day simple moving average is $30.49 and its 200-day simple moving average is $29.92. The stock has a market cap of $4.12 billion, a P/E ratio of 20.26, a P/E/G ratio of 1.79 and a beta of 1.29. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.36 and a current ratio of 1.73.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.05. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business had revenue of $1.28 billion during the quarter, compared to analysts' expectations of $1.22 billion. As a group, research analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insider Activity at Option Care Health

In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the firm's stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now owns 247,317 shares of the company's stock, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the business's stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the sale, the director now owns 21,339 shares of the company's stock, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the company's stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares of the company's stock, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.64% of the stock is owned by insiders.

Institutional Investors Weigh In On Option Care Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Blue Trust Inc. grew its holdings in shares of Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock worth $81,000 after purchasing an additional 377 shares during the last quarter. GAMMA Investing LLC grew its holdings in Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company's stock worth $28,000 after acquiring an additional 471 shares during the last quarter. Trust Point Inc. increased its position in Option Care Health by 2.6% in the 3rd quarter. Trust Point Inc. now owns 24,124 shares of the company's stock valued at $755,000 after acquiring an additional 622 shares during the period. Nisa Investment Advisors LLC raised its stake in shares of Option Care Health by 5.4% during the second quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company's stock valued at $376,000 after acquiring an additional 690 shares during the last quarter. Finally, State of Alaska Department of Revenue lifted its holdings in shares of Option Care Health by 3.8% during the third quarter. State of Alaska Department of Revenue now owns 19,871 shares of the company's stock worth $621,000 after purchasing an additional 735 shares during the period. Institutional investors own 98.05% of the company's stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.